JP2022533861A5 - - Google Patents
Info
- Publication number
- JP2022533861A5 JP2022533861A5 JP2022512708A JP2022512708A JP2022533861A5 JP 2022533861 A5 JP2022533861 A5 JP 2022533861A5 JP 2022512708 A JP2022512708 A JP 2022512708A JP 2022512708 A JP2022512708 A JP 2022512708A JP 2022533861 A5 JP2022533861 A5 JP 2022533861A5
- Authority
- JP
- Japan
- Prior art keywords
- specific
- mutant peptide
- neoplasm
- cells
- neoepitopes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962842800P | 2019-05-03 | 2019-05-03 | |
| US62/842,800 | 2019-05-03 | ||
| US201962880965P | 2019-07-31 | 2019-07-31 | |
| US62/880,965 | 2019-07-31 | ||
| US201962932654P | 2019-11-08 | 2019-11-08 | |
| US201962932651P | 2019-11-08 | 2019-11-08 | |
| US62/932,651 | 2019-11-08 | ||
| US62/932,654 | 2019-11-08 | ||
| PCT/US2020/031357 WO2020227233A2 (en) | 2019-05-03 | 2020-05-04 | Neoantigens in cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022533861A JP2022533861A (ja) | 2022-07-26 |
| JP2022533861A5 true JP2022533861A5 (enExample) | 2023-05-16 |
Family
ID=73050870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022512708A Pending JP2022533861A (ja) | 2019-05-03 | 2020-05-04 | がんにおける新抗原 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220125900A1 (enExample) |
| EP (2) | EP3963335B1 (enExample) |
| JP (1) | JP2022533861A (enExample) |
| CA (1) | CA3138867A1 (enExample) |
| WO (1) | WO2020227233A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250232833A1 (en) * | 2024-01-13 | 2025-07-17 | Noergaard Anders Kaare | Cyclin D1 Based Cancer Vaccine |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2450368A1 (en) * | 2007-01-30 | 2012-05-09 | Epivax, Inc. | Regulatory t cell epitopes, compositions and uses thereof |
| EP2569633B1 (en) * | 2010-05-14 | 2016-02-10 | The General Hospital Corporation | Compositions and methods of identifying tumor specific neoantigens |
| EP2983702A2 (en) * | 2013-04-07 | 2016-02-17 | The Broad Institute, Inc. | Compositions and methods for personalized neoplasia vaccines |
| CA3060569A1 (en) * | 2017-04-19 | 2018-10-25 | Gritstone Oncology, Inc. | Neoantigen identification, manufacture, and use |
| WO2020176726A1 (en) * | 2019-02-27 | 2020-09-03 | Epivax Oncology, Inc. | Improved compositions and methods for personalized neoplasia vaccines |
-
2020
- 2020-05-04 EP EP20729893.6A patent/EP3963335B1/en active Active
- 2020-05-04 JP JP2022512708A patent/JP2022533861A/ja active Pending
- 2020-05-04 CA CA3138867A patent/CA3138867A1/en active Pending
- 2020-05-04 EP EP22208033.5A patent/EP4198513A1/en not_active Withdrawn
- 2020-05-04 WO PCT/US2020/031357 patent/WO2020227233A2/en not_active Ceased
-
2021
- 2021-11-02 US US17/517,118 patent/US20220125900A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109801678B (zh) | 基于全转录组的肿瘤抗原预测方法及其应用 | |
| CN107076762B (zh) | 免疫原性突变体肽筛选平台 | |
| DK1987178T3 (en) | Process for the construction and screening of peptide structure libraries | |
| CN105779636B (zh) | 用于扩增人乳腺癌易感基因brca1和brca2编码序列的pcr引物及应用 | |
| JP2023134542A5 (enExample) | ||
| EP2080812A1 (en) | Compositions and methods of detecting post-stop peptides | |
| RU2004110239A (ru) | Модифицированный фактор ix | |
| JP2017534257A5 (enExample) | ||
| JP2022513047A (ja) | 個別化された癌ワクチンの作製のための癌変異の選択 | |
| CN110628890A (zh) | 测序质控标准品及其应用与产品 | |
| EP4110956A1 (en) | Hidden frame neoantigens | |
| CN111534602A (zh) | 一种基于高通量测序分析人类血型基因型的方法及其应用 | |
| JP2023522512A5 (enExample) | ||
| CN107312861B (zh) | 一种b-all患者预后风险评估标记物 | |
| CN103374628B (zh) | 先天性心脏病相关基因fam71a及其应用 | |
| CN111696628A (zh) | 新生抗原的鉴定方法 | |
| JP2022533861A5 (enExample) | ||
| CN105803054A (zh) | 试剂盒及其在检测唇腭裂相关基因中的用途 | |
| CN104450727A (zh) | X-连锁低磷酸盐血症性佝偻病的致病基因及其编码蛋白质和应用 | |
| CN107523629A (zh) | 无头精子症致病基因新突变及其应用 | |
| JP7793539B2 (ja) | 免疫原性応答を誘発すると予測される１つ又は複数のソースタンパク質の１つ又は複数の候補領域を識別する方法及びシステム並びにワクチンを作製する方法 | |
| AU2022319819A1 (en) | Identification of common tumor-specific t cell receptors and antigens | |
| CN117999350A (zh) | 一种t细胞表位序列的鉴定方法及其应用 | |
| JP2005531290A5 (enExample) | ||
| CN113272419A (zh) | 制备治疗性t淋巴细胞的方法 |